Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2011

01-01-2011 | Review

Changes in Ghrelin Levels Following Bariatric Surgery: Review of the Literature

Authors: Kevin Tymitz, Amy Engel, Sarah McDonough, Mary Pat Hendy, George Kerlakian

Published in: Obesity Surgery | Issue 1/2011

Login to get access

Abstract

Obesity is a severe health issue that is a global epidemic. Bariatric surgery is an accepted, popular, and effective therapy for weight loss. Ghrelin, a peptide secreted primarily by the fundus cells of the stomach, has been found to impact body weight by its influence on appetite. Although numerous studies have investigated serum ghrelin levels following bariatric surgery, there is no solid agreement yet as to the direction or magnitude of its change, or even its impact on weight loss. Some studies have found an increase in ghrelin, some have found a decrease, and others have found no change in ghrelin following bariatric surgery. The purpose of this review was to establish the impact of ghrelin changes following bariatric surgery.
Literature
1.
Karra E, Chandarana K, Batterham RL. The role of peptide YY in appetite regulation and obesity. J Physiol. 2009;587.1:19–25.CrossRef
2.
Couce MA, Cottam D, Esplen J, et al. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg. 2006;16:870–8.CrossRefPubMed
3.
Ianelli A, Dainese R, Piche T. Laparoscopic sleeve gastrectomy for morbid obesity. WJG. 2008;14:821–7.CrossRef
4.
Faraj M, Havel PJ, Phelis S, et al. Plasma acylation-simulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–602.CrossRefPubMed
5.
Fruhbeck G, Rotellar F, Hernandez-Lizoain JL, et al. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg. 2004;14:1208–15.CrossRefPubMed
6.
7.
Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight and obesity. JAMA. 2005;293:1861–7.CrossRefPubMed
8.
Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37.CrossRefPubMed
9.
Leonetti F, Silecchia G, Iacobellis G, et al. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab. 2003;88:4227–31.CrossRefPubMed
10.
Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714–9.CrossRefPubMed
11.
Lee H, Te C, Koshy S, et al. Does ghrelin really matter after bariatric surgery? Surg Obes Relat Dis. 2006;2:538–48.CrossRefPubMed
12.
Stoeckli R, Chanda R, Langer I, et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004;12:346–50.CrossRefPubMed
13.
Lin E, Gletsu N, Fugate K, et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg. 2004;139:780–4.CrossRefPubMed
14.
Geloneze B, Tambascia MA, Pilla VF, et al. Ghrelin: a gut hormone: effect of gastric bypass surgery. Obes Surg. 2003;13:17–22.CrossRefPubMed
15.
Langer FB, Hoda MAR, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.CrossRefPubMed
16.
Hanusch-Enserer U, Brabant G, Roden M. Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. Comment N Engl J Med. 2003;348:2159–60.CrossRef
17.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.CrossRefPubMed
18.
Chan JL, Mun EC, Stoyneva V, et al. Peptide YY levels are elevated after gastric bypass surgery. Obesity. 2006;14:194–8.CrossRefPubMed
19.
Morinigo R, Casamitjana R, Moize V, et al. Short term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res. 2004;2:1108–16.CrossRef
20.
Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of the procedure? Obes Surg. 2006;16:554–9.CrossRefPubMed
21.
Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after roux-en-Y gastric bypass and sleeve gastrectomy. Ann Surg. 2008;247:401–7.CrossRefPubMed
22.
Holdstock C, Engstrom BE, Ohrvall M, et al. Ghrelin and adipose tissue regulator peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88:3177–83.CrossRefPubMed
23.
Schindler K, Prager G, Ballaban T, et al. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behavior and body weight. Eur J Clin Invest. 2004;34:549–54.CrossRefPubMed
24.
Stratis C, Alexandrides T, Vagenas K, et al. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg. 2006;16:752–8.CrossRefPubMed
25.
Sundbom M, Holdstock C, Engstrom BE, et al. Early changes in ghrelin following roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg. 2007;17:304–10.CrossRefPubMed
26.
Haider DG, Schindler K, Prager G, et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92:1168–71.CrossRefPubMed
27.
Whitson BA, Leslie DB, Kellogg TA, et al. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res. 2007;141:31–9.CrossRefPubMed
28.
Uzzan B, Catheline JM, Lagorce C, et al. Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients. Obes Surg. 2007;17:1159–64.CrossRefPubMed
29.
Ram E, Vishne T, Diker D, et al. Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels. Obes Surg. 2005;15:1118–23.CrossRefPubMed
30.
Mancini MC, Costa AP, deMelo ME, et al. Effects of gastric bypass on spontaneous growth hormone and ghrelin release profiles. Obesity. 2006;14:383–7.CrossRefPubMed
31.
Borg CM, le Roux CW, Ghatei MA, et al. Progressive rise in gut hormone levels after roux-en-y gastric bypass suggests gut adaption and explains altered satiety. Br J Surg. 2006;93:210–5.CrossRefPubMed
32.
Liou JM, Lin JT, Lee WJ, et al. The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery. Obes Surg. 2008;18:84–9.CrossRefPubMed
33.
Shultz M, DeGroote S. Medline SDI services: how do they compare. J Med Libr Assoc. 2003;91:460–7.PubMed
Metadata
Title
Changes in Ghrelin Levels Following Bariatric Surgery: Review of the Literature
Authors
Kevin Tymitz
Amy Engel
Sarah McDonough
Mary Pat Hendy
George Kerlakian
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 1/2011
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0311-z

Other articles of this Issue 1/2011

Obesity Surgery 1/2011 Go to the issue

Clinical Research

BioEnterics® Intragastric Balloon (BIB®). Single Ambulatory Center Spanish Experience with 714 Consecutive Patients Treated with One or Two Consecutive Balloons

Physiology Research

Physical Fitness in Morbidly Obese Patients: Effect of Gastric Bypass Surgery and Exercise Training

Clinical Research

Prevalence of Endocrine Diseases in Morbidly Obese Patients Scheduled for Bariatric Surgery: Beyond Diabetes

Clinical Research

Laparoscopic Gastric Banding in Over 60s

Clinical Report

Laparoscopic Gastric Bypass as a Revision Procedure After Transoral Gastroplasty

Clinical Research

Bariatric Surgery Reverses Natural Killer (NK) Cell Activity and NK-Related Cytokine Synthesis Impairment Induced by Morbid Obesity